Case report of penile cancer recurrence treated with cetuximab combined with anlotinib.
Shuang DaiYan-Yang LiuTao LiuYu ZhangDe-Yun LuoPublished in: Clinical case reports (2022)
Penile squamous cell carcinoma with pelvic lymph node metastases/recurrence has a poor prognosis. We reported a case with recurrent pSCC was administered cetuximab and anlotinib after failure of first-line treatment and achieved an effective response. Cetuximab combined with anlotinib may be a new choice for relapsed pSCC.
Keyphrases
- poor prognosis
- locally advanced
- lymph node
- metastatic colorectal cancer
- squamous cell carcinoma
- rectal cancer
- long non coding rna
- case report
- neoadjuvant chemotherapy
- wild type
- papillary thyroid
- free survival
- acute lymphoblastic leukemia
- acute myeloid leukemia
- lymph node metastasis
- diffuse large b cell lymphoma
- multiple myeloma
- radical prostatectomy
- squamous cell
- prostate cancer
- young adults
- newly diagnosed
- decision making
- early stage